Chemical Research in Toxicology
ARTICLE
Other mechanisms of cytotoxicity implicate quinone arylation
which involves activation of signaling pathways such as the
pancreatic endoplasmic reticulum kinase (PERK) C/EBP homo-
(11) Land, E. J., Perona, A., Ramsden, C. A., and Riley, P. A. (2009)
Dopamine quinone chemistry: a study of the influence of amide, amidine
and guanidine substituents [-NH-CX-Y] on the mode of reaction.
Org. Biomol. Chem. 7, 944–950.
37
logous protein (CHOP) induction. Interestingly, catechol es-
trogen 3,4-quinones have been implicated as initiators of breast,
prostate, and other cancers through the formation of depurinat-
(
12) Jordan, A. M., Khan, T. H., Malkin, H., Osborn, H. M., Photiou,
A., and Riley, P. A. (2001) Melanocyte-directed enzyme prodrug therapy
MDEPT): development of second generation prodrugs for targeted
treatment of malignant melanoma. Bioorg. Med. Chem. 9, 1549–
558.
13) Land, E. J., Ramsden, C. A., and Riley, P. A. (2006) Toxicolo-
(
3
8,39
ing adducts.
The relative ease with which the products of
halogen-substituted catechols form adducts suggests that the
generation of dibenzodioxin derivatives from polyhalocatechols
may have toxicological and occupational health implications.
1
(
gical Aspects of Melanin and Melanogenesis, in The Pigmentary System:
Physiology and Pathophysiology (Nordlund, J. J., Boissy, R. E., Hearing,
V. J., King, R. A., Oetting, W. S., and Ortonne, J.-P.) 2nd ed., pp 354-
’
ASSOCIATED CONTENT
Supporting Information. H NMR spectrum of isomers
394, Blackwell, Oxford, U.K.
1
S
(14) Riley, P. A. (2004) Melanoma and the problem of malignancy.
b
1
6 (X = Cl). This material is available free of charge via the
Tohoku J. Exp. Med. 204, 1–9.
15) Land, E. J., Ramsden, C. A., and Riley, P. A. (2007) The
(
Internet at http://pubs.acs.org.
mechanism of suicide-inactivation of tyrosinase: a substrate structure
investigation. Tohoku J. Exp.Med. 212, 341–348.
’
AUTHOR INFORMATION
(
16) Land, E. J., Ramsden, C. A., Riley, P. A., and Stratford, M. R. L.
2008) Evidence consistent with the requirement of cresolase activity for
suicide inactivation of tyrosinase. Tohoku J. Exp.Med. 216, 231–238.
17) Ramsden, C. A., Stratford, M. R. L., and Riley, P. A. (2009) The
(
Corresponding Author
*E-mail: c.a.ramsden@chem.keele.ac.uk.
(
influence of catechol structure on the suicide-inactivation of tyrosinase.
Org. Biomol. Chem. 7, 3388–3390.
’
ACKNOWLEDGMENT
We thank John Clews (Keele) for the synthesis of 4-bromo-
(18) Land, E. J., Ramsden, C. A., Riley, P. A., and Stratford, M. R. L.
(
2008) Studies of para-quinomethane formation during the tyrosinase-
catalyzed oxidation of 4-alkylcatechols. ARKIVOC (ii) 258–267.
19) Mason, H. S., Fowlks, W. L., and Peterson, E. (1955) Oxygen
catechol and Martin Christlieb, Stuart Conway, and Jess Healy
Department of Chemistry, University of Oxford) for running
the NMR spectra.
(
(
transfer and electron transport by the phenolase complex. J. Am. Chem.
Soc. 77, 2914–2915.
’
REFERENCES
(20) Pomerantz, S. H. (1966) The tyrosine hydroxylase activity of
(
1) Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., and
Monks, T. J. (2000) Role of quinones in toxicology. Chem. Res. Toxicol.
3, 135–160.
2) Naish, S., Holden, J. L., Cooksey, C. J., and Riley, P. A. (1988)
mammalian tyrosinase. J. Biol. Chem. 241, 161–168.
(21) Mason, H. S. (1955) In Advances in Enzymology (Nord, F. F.,
Ed.) Vol. 16, pp 105-184, Interscience Publishers Inc., New York.
(22) Lerner, A. B., Fitzpatrick, T. B., Calkins, E., and Summerson,
W. H. (1949) Mammalian tyrosinase: preparation and properties. J. Biol.
Chem. 178, 185–195.
(23) Lerch, K. (1981) Copper monooxygenases: tyrosinase and
dopamine γ-hydroxylase. In Metal Ions in Biological Systems, Vol. 13.
(Sigel, H., Ed.) pp 143-186, Marcel Decker, New York.
(24) Land, E. J., Ramsden, C. A., and Riley, P. A. (2003) Tyrosinase
autoactivation and the chemistry of ortho-quinone amines. Acc. Chem.
Res. 36, 300–308.
(25) Manini, P., Napolitano, A., Westerhof, W., Riley, P. A., and
d’Ischia, M. (2009) A reactive ortho-quinone generated by tyrosinase-
catalysed oxidation of the skin-depigmenting agent monobenzone: self-
coupling and thiol-conjugation reactions and possible implications for
melanocyte toxicity. Chem. Res. Toxicol. 22, 1398–1405.
1
(
The major primary cytotoxic product of 4-hydroxyanisole oxidation by
mushroom tyrosinase is 4-methoxy ortho-benzoquinone. Pigm. Cell Res.
1, 382–385.
(
3) Land, E. J., Cooksey, C. J., and Riley, P. A. (1990) Reaction
kinetics of 4-methoxy ortho-benzoquinone in relation to its mechanism
of cytotoxicity: a pulse radiolysis study. Biochem. Pharmacol. 39, 1133–1135.
(
4) Riley, P. A. (1991) Melanogenesis: a realistic target for anti-
melanoma therapy? Eur. J. Cancer 27, 1172–1177.
5) Naish-Byfield, S., Cooksey, C. J., Latter, A. M., Johnson, C. I., and
(
Riley, P. A. (1991) In vitro assessment of the structure-activity relation-
ship of tyrosinase-dependent cytotoxicity of a series of substituted
phenols. Melanoma Res. 1, 273–287.
(
6) Cooksey, C. J., Land, E. J., Ramsden, C. A., and Riley, P. A.
(1995) Tyrosinase-mediated cytotoxicity of 4-substituted phenols:
(26) Ding, Y.-S., Shiue, C.-Y., Fowler, J. S., Wolf, A. P., and
1
8
quantitative structure-thiol-reactivity relationships of the derived
o-quinones. Anti-Cancer Drug Des. 10, 119–129.
(
Plenevaux, A. (1990) No-carrier-added (NCA) aryl[ F]fluorides via
the nucleophilic aromatic substitution of electron-rich aromatic rings.
J. Fluorine Chem. 48, 189–206.
7) Cooksey, C. J., Land, E. J., Rushton, F. A. P., Ramsden, C. A., and
Riley, P. A. (1996) Tyrosinase-mediated cytotoxicity of 4-substituted
phenols: Use of QSAR to forecast reactivities of thiols towards the
derived ortho-quinones. Quant. Struct.-Act. Relat. 15, 498–503.
(27) Naish-Byfield, S., and Riley, P. A. (1998) Tyrosinase autoacti-
vation and the problem of the lag period. Pigm. Cell Res. 11, 127–133.
(28) Cooksey, C. J., Garratt, P. J., Land, E. J., Pavel, S., Ramsden,
C. A., Riley, P. A., and Smit, N. P. M. (1997) Evidence of the indirect
formation of the catecholic intermediate substrate responsible for
the autoactivation kinetics of tyrosinase. J. Biol. Chem. 272, 26226–
26235.
(8) Riley, P. A., Cooksey, C. J., Johnson, C. I., Land, E. J., Latter,
A. M., and Ramsden, C. A. (1997) Melanogenesis-targeted anti-
melanoma pro-drug development: Effect of side-chain variations on
the cytotoxicity of tyrosinase-generated ortho-quinones in a model
screening system. Eur. J. Cancer 33, 135–143.
(29) Ramsden, C. A., and Riley, P. A. (2010) Mechanistic studies of
tyrosinase suicide inactivation. ARKIVOC (i) 260–274.
(30) Katritzky, A. R., Ramsden, C. A., Joule, J. A., and Zhdankin,
V. V. (2010) Handbook of Heterocyclic Chemistry 3rd ed., Elsevier,
Oxford, U.K.
(9) Borovansky, J., Edge, R., Land, E. J., Navaratnam, S., Pavel, S.,
Ramsden, C. A., Riley, P. A., and Smit, N. P. M. (2006) Mechanistic
studies of melanogenesis: the influence of N-substitution on dopamine
quinone cyclization. Pigm. Cell Res. 19, 170–178.
ꢀ
(10) Land, E. J., Ramsden, C. A., and Riley, P. A. (2006) An MO
(31) Frejka, J., Sefr ꢁa nek, B., and Zika, J. (1937) Nouveau mode de
study of regioselective amine addition to ortho-quinones relevant to
melanogenesis. Tetrahedron 62, 4884–4891.
pr ꢁe paration des d ꢁe riv ꢁe s halogens du dioxyde de dioxy-di-o-ph ꢁe nyl ꢂe ne.
Collect. Czech. Chem. Commun. 9, 238–246.
3
55
dx.doi.org/10.1021/tx100315n |Chem. Res. Toxicol. 2011, 24, 350–356